Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Times Interest Earned (2022 - 2025)

Tarsus Pharmaceuticals (TARS) has 4 years of Times Interest Earned data on record, last reported at -$3.6 in Q4 2025.

  • For Q4 2025, Times Interest Earned rose 65.89% year-over-year to -$3.6; the TTM value through Dec 2025 reached -$7.94, up 48.29%, while the annual FY2025 figure was -$7.94, 48.29% up from the prior year.
  • Times Interest Earned reached -$3.6 in Q4 2025 per TARS's latest filing, up from -$6.41 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$3.6 in Q4 2025 and bottomed at -$61.78 in Q1 2022.
  • Average Times Interest Earned over 4 years is -$25.33, with a median of -$18.78 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: crashed 330.16% in 2023, then skyrocketed 78.43% in 2024.
  • A 4-year view of Times Interest Earned shows it stood at -$21.76 in 2022, then plummeted by 106.5% to -$44.94 in 2023, then soared by 76.5% to -$10.56 in 2024, then skyrocketed by 65.89% to -$3.6 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$3.6 in Q4 2025, -$6.41 in Q3 2025, and -$9.9 in Q2 2025.